We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Transplantation of Ovarian Cortex to Restore Fertility (ovatrspl)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01442584
Recruitment Status : Unknown
Verified July 2011 by Hadassah Medical Organization.
Recruitment status was:  Recruiting
First Posted : September 28, 2011
Last Update Posted : September 28, 2011
Sponsor:
Information provided by:

Study Description
Brief Summary:
Ovarian transplantation has been shown to restore fertility.

Condition or disease Intervention/treatment
Pregnancy Procedure: ovarian transplantation

Detailed Description:
The investigators transplant ovarian cortex previously collected from the patient prior to cancer treatment.

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 5 participants
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Transplantation of Ovarian Cortex to Restore Fertility
Study Start Date : July 2011
Estimated Primary Completion Date : December 2015
Estimated Study Completion Date : January 2016
Arms and Interventions

Arm Intervention/treatment
Experimental: fertility restoration by transplantation
fertility restoration by transplantation of ovarian cortex slivers that were cryopreserved prior to chemotherapy
Procedure: ovarian transplantation
ovarian transplantation
Other Name: frozen thawed ovarian cortex transplantation


Outcome Measures

Primary Outcome Measures :
  1. pregnancy [ Time Frame: 3-6 months ]
    we will start IVF within 3 months


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 54 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients who froze ovarian tissue

Exclusion Criteria:

  • malignant cells in ovary
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01442584


Contacts
Contact: ariel revel, md 97226777111 ext 74399 arielr2@hadassah.org.il

Locations
Israel
Hadassah Recruiting
Jerusalem, Israel
Contact: ariel revel, md    97226777111 ext 74399    arielr2@hadassah.org.il   
Principal Investigator: ariel revel, md         
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Study Chair: Ariel Revel, MD Hadassah
More Information

Responsible Party: hadassah, Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01442584     History of Changes
Other Study ID Numbers: ovarian transplant- HMO-CTIL
First Posted: September 28, 2011    Key Record Dates
Last Update Posted: September 28, 2011
Last Verified: July 2011

Keywords provided by Hadassah Medical Organization:
ovary
cortex
transplantation